Literature DB >> 7006655

Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities.

L M Shapiro, A P Howat, M M Calter.   

Abstract

Frequent abnormalities of left ventricular function were detected in 212 established diabetic patients using non-invasive techniques. Diabetics without angina or heart failure (n = 185) were significantly different from normal subjects (n = 50) in beat-to-beat variation, ratio of pre-ejection period to left ventricular ejection time, pre-ejection period index, isovolumic relaxation time, and interval from minimal dimension to mitral valve opening. Diabetics with angina (n = 18) were similar to control subjects with angina (n = 25); they showed a significant dimension change during the isovolumic period as compared with other diabetics and normals. Sixteen diabetics without angina also showed outward motion during the isovolumic period (incoordinate relaxation) and 13 had abnormal systolic time intervals. Four diabetics suffered a myocardial infarction during the study period; all had previously shown incoordination. Comparison of diabetics with a diastolic blood pressure below 100 mmHg and between 100 and 125 mmHg showed that the latter had a thicker posterior wall; the enlarged systolic dimension and reduced fractional shortening were the result of the inclusion of five of the 11 diabetic subjects with heart failure in the hypertensive group. Insulin-dependent diabetics tend to have more pronounced abnormalities of left ventricular function than those not requiring insulin. Patients selected from a diabetic clinic frequently have impaired left ventricular function, and ventricular hypertrophy, when present, in primarily caused by hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7006655      PMCID: PMC482499          DOI: 10.1136/hrt.45.2.122

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  22 in total

1.  Evidence for cardiomyopathy in familial diabetes mellitus.

Authors:  T J Regan; M M Lyons; S S Ahmed; G E Levinson; H A Oldewurtel; M R Ahmad; B Haider
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Diabetic cardiomyopathy.

Authors:  R I Hamby; S Zoneraich; L Sherman
Journal:  JAMA       Date:  1974-09-23       Impact factor: 56.272

3.  New type of cardiomyopathy associated with diabetic glomerulosclerosis.

Authors:  S Rubler; J Dlugash; Y Z Yuceoglu; T Kumral; A W Branwood; A Grishman
Journal:  Am J Cardiol       Date:  1972-11-08       Impact factor: 2.778

4.  Systolic time intervals in heart failure in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Circulation       Date:  1968-02       Impact factor: 29.690

5.  Diabetic cardiomyopathy: the preclinical phase.

Authors:  B I Seneviratne
Journal:  Br Med J       Date:  1977-06-04

6.  Preclinical abnormality of left ventricular function in diabetes mellitus.

Authors:  S S Ahmed; G A Jaferi; R M Narang; T J Regan
Journal:  Am Heart J       Date:  1975-02       Impact factor: 4.749

7.  Echocardiographic assessment of abnormal left ventricular relaxation in man.

Authors:  M T Upton; D G Gibson; D J Brown
Journal:  Br Heart J       Date:  1976-10

8.  Diabetic cardiopathy. Quantitative histological studies of the heart from young juvenile diabetics.

Authors:  T Ledet
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-09

9.  Hyperglycaemia and diabetes mellitus.

Authors:  R J Jarrett; H Keen
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

10.  Is hyperviscosity a treatable component of diabetic microcirculatory disease?

Authors:  A J Barnes; P Locke; P R Scudder; T L Dormandy; J A Dormandy; J Slack
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

View more
  32 in total

1.  Alterations of left ventricular function in women with insulin-dependent diabetes mellitus during pregnancy.

Authors:  C M Schannwell; M Schneppenheim; S M Perings; T Zimmermann; G Plehn; B E Strauer
Journal:  Diabetologia       Date:  2003-02-14       Impact factor: 10.122

2.  Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.

Authors:  G A Oswald; C C Smith; D J Betteridge; J S Yudkin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

3.  Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus.

Authors:  L Irace; D Iarussi; I Guadagno; M A Tedesco; B Perna; G Ratti; P Spadaro; G Rogliani; V Armentano; A Iacono
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

4.  Chronic effects of streptozotocin diabetes on myocardial sensitivity in the rat.

Authors:  S Ramanadham; T E Tenner
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

5.  Exercise-induced diastolic abnormalities in type 1 (insulin-dependent) diabetic patients without overt heart disease.

Authors:  G Jermendy; S Khoór; M Z Koltai; G Pogátsa
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

Review 6.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

7.  Effects of dynamic exercise and metabolic control on left ventricular performance in insulin-dependent diabetes mellitus.

Authors:  G Cerasola; M Donatelli; S Cottone; G D'Ignoto; L Grasso; M L Morici; C Terrizzi; S Verga; G D Bompiani
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

8.  Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study.

Authors:  J W Park; A G Ziegler; H U Janka; W Doering; H Mehnert
Journal:  Klin Wochenschr       Date:  1988-09-01

Review 9.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  Observations on atrial natriuretic peptide, sympathetic activity and renal Ca2+ pump in diabetic and hypertensive rats.

Authors:  A Sahai; P K Ganguly
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.